Search
for
Sort by
Research 571–600 of 1000+
- Unilateral Gynecomastia Induced by Treatment With 1 mg of Oral Finasteride
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Micropigmentation: Camouflaging Scalp Alopecia and Scars in Korean Patients
- Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3
- Persistent Sexual and Nonsexual Adverse Effects of Finasteride in Younger Men
- Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS
- Inhibitors of 5α -Reductase Type I in LNCaP Cells from the Roots of Angelica koreana
- Dermatologic Conditions in Transgender Populations
- Meta-Analysis of Randomized Clinical Trials of Finasteride
- Postmenopausal virilization after spousal use of topical androgens
- Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
- The endocrinology of baldness
- Evaluation of the effect of injection of dutasteride as mesotherapeutic tool in treatment of androgenetic alopecia in males
- Co-secretion of testosterone and cortisol by a functional adrenocortical oncocytoma
- Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance
- 5alpha-reductase inhibitors - a new hope in dermatology?
- Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness?
- Alopecia in general medicine
- Nonclassic 21-hydroxylase deficiency
- Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis
- A systematic review of the effect of platelet‐rich plasma on androgenetic alopecia of women
- Flavonoids and saponins: What have we got or missed?
- Ovarian Hilus-Cell Hyperplasia and High Serum Testosterone in a Patient With Postmenopausal Virilization
- Finasteride and the Uncertainties of Establishing Harms
- Combing the genome for the root cause of baldness
- Normalized androgen ratio: its application to clinical dermatology
- Quintaquinone, a Merosesquiterpene from the Yellow Sponge Verongula cf. rigida Esper
- Off-label uses of retinoids in dermatology
- Increased retinol‐binding protein (RBP) 4 and anti‐RBP4 antibody in alopecia areata
- Nuclear and cytosol Androgen Receptor in Androgen Dependent Dermatoses in Female Patients